SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales figure stood at Rs. 1568.22 millions for the March 2026 quarter. The mentioned figure indicates a growth of about 35.57% as compared to Rs. 1156.76 millions during the year-ago period.Profit for the quarter ended March 2026 rises by 74.43% to Rs. 252.90  millions from Rs. 144.99 millions.Operating profit for the quarter ended March 2026 rose to 397.96 millions as compared to 266.64 millions of corresponding quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 1568.22 1156.76 35.57 5030.59 3701.97 35.89 5030.59 3701.97 35.89
Other Income 10.58 7.65 38.30 28.59 19.20 48.91 28.59 19.20 48.91
PBIDT 397.96 266.64 49.25 1210.88 823.64 47.02 1210.88 823.64 47.02
Interest 28.87 24.92 15.85 109.70 98.78 11.05 109.70 98.78 11.05
PBDT 369.09 241.72 52.69 1092.89 724.86 50.77 1092.89 724.86 50.77
Depreciation 52.61 50.79 3.58 197.94 182.58 8.41 197.94 182.58 8.41
PBT 316.48 190.93 65.76 894.95 542.28 65.03 894.95 542.28 65.03
TAX 63.58 45.94 38.40 221.46 143.38 54.46 221.46 143.38 54.46
Deferred Tax -18.46 -15.87 16.32 -8.87 -15.89 -44.18 -8.87 -15.89 -44.18
PAT 252.90 144.99 74.43 673.49 398.90 68.84 673.49 398.90 68.84
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 25.38 23.05 10.09 24.07 22.25 8.19 24.07 22.25 8.19

Kwality Pharma Share Price

2389.55 6.70 (0.28%)
05-Jun-2026 10:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1792.25
Dr. Reddys Lab 1272.50
Cipla 1391.10
Zydus Lifesciences 1091.00
Lupin 2277.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×